BioCote® leads the way in healthcare innovation as the industry continuously aims to establish more hygienic environments and implement rigorous hygiene practices. Our antimicrobial additives play a crucial role in inhibiting the growth of microbes on surfaces, significantly reducing the possibility of contamination. This breakthrough technology opens up exciting possibilities for enhanced design and functionality.
In a recent feature in British Plastics and Rubber magazine, we shared the advantages of integrating BioCote® technology into healthcare products. As a frontrunner in the field, we collaborate with forward-thinking brands to develop solutions that not only provide reliable protection but also uphold a cleaner and more aesthetically pleasing finish. Through our collaboration, we empower the healthcare industry to create spaces that are both visually appealing and hygienically optimised.
How BioCote® Technology Can Help Reduce Cross-Contamination of Microbes: Eris variant of Coronavirus
Recent hospitalisation data reveals that a new variant of coronavirus has emerged, the Eris variant, now accounts for a significant portion of COVID-19 cases in the UK. In the face of this new challenge, it becomes crucial to explore innovative solutions to reduce the risk of contamination and the spread of this and other microbes.
BioCote® Taggant Technology: Unmasking Antimicrobial Additives
Taggant technology is the use of microscopic particles that emit light when exposed to specific wavelengths. Traditionally used in counter-fraud technologies, BioCote® has ingeniously adapted this concept to highlight the presence of antimicrobial additives in products.
